Viking Therapeutics, Inc.
NASDAQ:VKTX
60.6 (USD) • At close November 12, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||||
| Net Income
| -85.895 | -68.867 | -54.99 | -39.495 | -25.779 | -22.063 | -20.578 | -14.732 | -23.404 | -21.884 | -0.146 | -0 |
| Depreciation & Amortization
| 0.292 | 0.291 | 0.296 | 0.277 | 0.26 | 0.477 | 1.377 | 1.942 | 1.025 | 0 | 0 | 0 |
| Deferred Income Tax
| -8.202 | 0 | 3.906 | 3.768 | 0.473 | -0.392 | -1.283 | -1.788 | -0.894 | 0 | 0 | 0 |
| Stock Based Compensation
| 16.75 | 8.673 | 6.1 | 5.818 | 3.743 | 2.608 | 1.451 | 1.794 | 2.601 | 0.006 | 0 | 0 |
| Change In Working Capital
| 3.548 | 10.189 | -2.927 | 7.717 | -3.783 | 0.823 | 1.771 | 0.85 | 0.62 | 21.941 | 0.025 | 0 |
| Accounts Receivables
| 0.321 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| -1.018 | 7.085 | -2.544 | 1.555 | 1.472 | -0.508 | 0.264 | 0.677 | 0.219 | 0.19 | 0.02 | 0 |
| Other Working Capital
| 4.245 | 3.104 | -0.383 | 6.162 | -5.255 | 1.331 | 1.508 | 0.173 | 0.401 | 21.751 | 0.005 | 0 |
| Other Non Cash Items
| 0.131 | 1.317 | 0.029 | 0.138 | 0.334 | -0.208 | 2.503 | 0.863 | 11.319 | -1.655 | 0.043 | 0 |
| Operating Cash Flow
| -73.376 | -48.397 | -47.586 | -21.777 | -24.752 | -18.755 | -14.758 | -11.071 | -8.731 | -1.591 | -0.078 | -0 |
| Investing Activities: | ||||||||||||
| Investments In Property Plant And Equipment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -478.303 | -121.431 | -168.015 | -280.636 | -362.406 | -348.204 | -22.526 | -16.922 | -16.033 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 299.217 | 176.184 | 205.975 | 322.203 | 369.869 | 82.475 | 20.796 | 19.952 | 2.563 | 0 | 0 | 0 |
| Other Investing Activites
| -179.086 | 0.055 | 0.038 | 0.042 | 0.007 | -0.266 | -0.002 | 0.003 | -0.013 | 0 | 0 | 0 |
| Investing Cash Flow
| -179.086 | 54.753 | 37.96 | 41.567 | 7.463 | -265.729 | -1.73 | 3.03 | -13.47 | 0 | 0 | 0 |
| Financing Activities: | ||||||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 276.528 | 0.826 | 7.587 | 1.246 | 1.038 | 296.607 | 22.352 | 11.549 | 22.633 | 0 | 0 | 0 |
| Common Stock Repurchased
| -0.007 | -6.795 | -0.001 | -0 | -0 | -0 | -0 | -0 | -0.418 | -0 | -0.003 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 278.497 | 10.132 | -0.706 | -0.296 | -0.151 | 7.501 | 0.126 | -1.083 | 22.633 | 2.168 | 0.26 | 0 |
| Financing Cash Flow
| 271.376 | 4.163 | 6.88 | 0.95 | 0.887 | 300.275 | 22.4 | 10.348 | 22.214 | 2.168 | 0.258 | 0 |
| Other Information: | ||||||||||||
| Effect Of Forex Changes On Cash
| -0.03 | -0.258 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 18.884 | 10.261 | -2.746 | 20.74 | -16.402 | 15.791 | 5.913 | 2.307 | 0.013 | 0.576 | 0.18 | 0 |
| Cash At End Of Period
| 55.516 | 36.632 | 26.371 | 29.117 | 8.377 | 24.779 | 8.988 | 3.076 | 0.769 | 0.756 | 0.18 | 0 |